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Spheroplasts were used to study the early interac-
tions of newly synthesized outer membrane protein
PhoE with periplasmic proteins employing a protein
cross-linking approach. Newly translocated PhoE pro-
tein could be cross-linked to the periplasmic chaperone
Skp at the periplasmic side of the inner membrane. To
study the timing of this interaction, a PhoE-dihydrofo-
late reductase hybrid protein was constructed that
formed translocation intermediates, which had the
PhoE moiety present in the periplasm and the dihydro-
folate reductase moiety tightly folded in the cytoplasm.
The hybrid protein was found to cross-link to Skp, indi-
cating that PhoE closely interacts with the chaperone
when the protein is still in a transmembrane orientation
in the translocase. Removal of N-terminal parts of PhoE
protein affected Skp binding in a cumulative manner,
consistent with the presence of two Skp-binding sites in
that region. In contrast, deletion of C-terminal parts
resulted in variable interactions with Skp, suggesting
that interaction of Skp with the N-terminal region is
influenced by parts of the C terminus of PhoE protein.
Both the soluble as well as the membrane-associated
Skp protein were found to interact with PhoE. The lat-
ter form is proposed to be involved in the initial inter-
action with the N-terminal regions of the outer mem-
brane protein.
The majority of the proteins destined for the extracytoplas-
mic environment in Escherichia coli are synthesized as precur-
sors in the cytoplasm that are translocated across the inner
IM1 in a non-native state. To reach their final conformation and
destiny they need to be prevented from premature folding and
degradation in the cytoplasm. It is well established that mo-
lecular chaperones and folding catalysts are required to chan-
nel proteins into productive export, folding, and assembly path-
ways. In the cytoplasm one of the first events that takes place
when a nascent PhoE emerges from the ribosome is the inter-
action with trigger factor, a cytoplasmic chaperone. Using a
cross-linking approach, the latter protein was found to interact
with nascent PhoE chains as short as 57 amino acids (1–3).
Subsequently, at a late co-translational or early post-transla-
tional stage the precursor protein interacts with SecB (4–6).
This SecBzprecursor complex is then targeted to SecA, the
peripheral subunit of the membrane-embedded SecYEG com-
plex (7). PhoE precursors are then translocated across the IM
in a non-native state. When appearing at the periplasmic side
of the IM, these polypeptides undergo complex folding pro-
cesses and have to be prevented from misfolding, aggregating,
and degrading. Proteins destined for the outer membrane or
the extracellular environment require correct targeting to
these locations. Periplasmic chaperones and folding catalysts
have been implicated to be involved in the folding and assembly
pathway of OMPs. It was demonstrated previously that OMPs
are exposed to the periplasmic chaperones during the assembly
process (8). A periplasmic system consisting of molecular chap-
erones and folding catalysts has been described (9, 10). Among
them, the peptidyl-prolyl isomerases (FkpA, SurA, RotA, and
PpiD) carry out the isomerization around the Xaa-Pro peptide
bond. In addition to the isomerase activity the FkpA and SurA
proteins were found to posses chaperone activity (11, 12). The
second type of folding catalysts are the protein disulfide
isomerases (Dsb proteins) carrying out disulfide bond forma-
tion and thiol-disulfide exchanges (13).
In addition, Skp functions as a molecular chaperone in the
periplasm of Gram-negative bacteria, possibly specifically re-
quired for the biogenesis of OMPs. Skp is a basic soluble pro-
tein in the periplasm, but it was also found in IM fractions (14,
15). The protein exists in two different states as was demon-
strated by their different sensitivity toward proteases (16). The
conversion between these states can be modulated in vitro by
phospholipids, lipopolysaccharides, and bivalent cations (16).
The function of these two different forms of Skp in vivo is not
yet known. Previously, it was demonstrated that Skp binds
selectively to OmpA and proteins of the bacterial porin family
(16, 17). In addition, non-OMPs seem to act as a substrate for
binding (18). Skp interacts with OmpA in close vicinity of the
IM, and it was found to be involved in the release of the OMP
from this membrane (15). In addition, cells defective in Skp and
the periplasmic protease DegP accumulate protein aggregates
in the periplasm (15). These results suggest that Skp is a
molecular chaperone involved in generating and maintaining
solubility of early folding intermediates of OMPs in the
periplasm.
The molecular mechanism of the PhoE assembly pathway
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has been investigated extensively in vivo and in vitro. How-
ever, little is known about which periplasmic chaperones and
folding catalysts are involved in the late stages of translocation
over the IM, in the release from the IM, and in the early stages
of folding in the periplasm. Furthermore, the order of interac-
tions with accessory proteins and the timing of the various
reactions are largely unknown. In the studies described in this
report, we used an unbiased approach to study these processes.
We present evidence that the initial interaction of the non-
native porin protein PhoE at the periplasmic side of the IM is
with Skp. This interaction occurs already early during trans-
location of PhoE, i.e. when PhoE is still in a transmembrane
orientation in the translocase. At the N terminus of PhoE,
two Skp-binding sites could be identified. In contrast to
OmpA, release of PhoE from the IM appeared not to be
dependent on Skp.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions—The E. coli K12 strain
MC4100 (F2 DlacU169 araD136 rpsL thi relA) was used for the sphero-
plast labeling experiments and for the isolation of lysate and inner
membrane vesicles (19). MC4100 and RC354c, containing a deletion in
the skp gene (17), were used for the isolation of periplasmic extracts
(20). BG87 (21) was used for the isolation of trigger factor-depleted
lysate as described before (2, 19). Top10F9 (Invitrogen, Carlsbad, CA)
was used for routine cloning procedures. Strains were routinely grown
in LB medium and the appropriate antibiotics. For pulse labeling ex-
periments a GB1 minimal medium was used (22) supplemented with
0.4% maltose as the carbon source and an 18-amino acid mixture (0.1
mM) (without Met and Cys).
Construction of Plasmids—Plasmid pNN100 containing the
phoE gene under control of the tac promoter was constructed previously
(23). Plasmids pC4Meth300PhoE, pC4Meth100PhoEDss, and
pC4Meth137PhoEDss were obtained by polymerase chain reaction
using pVG01 (24) as a template essentially as described in a previous
study (2). The latter two plasmids contain instead of a signal sequence
a Met and a Ser residue just as in pJP370 (25). Construction of plasmid
pAra300PhoE.DHFR was as follows: pC4Meth300PhoE was digested
with BamHI and HindIII and ligated to the BamHI-HindIII fragment of
pGEM4.DHFR containing the mouse dhfr gene (a gift from T. Langer,
Mu¨nchen, Germany). Subsequently, the phoE-dhfr fusion gene was
cloned downstream of the arabinose promoter on plasmid pMPMK4
(26). Plasmid pGAH317, carrying the wild-type skp gene, has been
described (27).
Spheroplast Labeling, Cross-linking, and Release—For pulse label-
ing of spheroplasts cells were grown in GB1 medium with casamino
acids during 7 h and then diluted for overnight growth in such a way
that the culture turbidity reached a value of ;0.5 (at 660 nm) the next
morning. 1.5 ml of cells was collected at 10,000 3 g for 2 min, washed
once with phosphate-buffered saline (0.15 M sodium chloride, 0.1 M
sodium phosphate, pH 7.0) and resuspended in 250 ml of 100 mM
Tris-HCl (pH 8.0). After addition of 250 ml of 100 mM Tris-HCl (pH 8.0),
1 M sucrose, the mixture was incubated for 10 min at 0 °C. After
addition of EDTA (4 mM) and lysozyme (50 mg/ml), 500 ml of cold H2O
was added immediately. Cells were incubated on ice for 15 min, and the
formation of spheroplasts was followed by phase contrast microscopy.
MgCl2 was added to a final concentration of 20 mM to stabilize the
spheroplasts, which were subsequently collected at 10,000 3 g for 2 min
and resuspended in 0.5 ml of spheroplast labeling medium (GB1 me-
dium containing 250 mM sucrose, 10 mM MgCl2). After 10-min incuba-
tion at 30 °C the spheroplasts were induced for the synthesis of PhoE by
adding 1 mM IPTG or of PhoE-DHFR by adding 0.1% arabinose. After
5-min incubation with IPTG or 10 min with arabinose, the spheroplasts
were pulsed for 1 min with 16.5 mCi of [35S]methionine (Amersham
Pharmacia Biotech), followed by a 5-min chase with 2 mM cold methi-
onine. During the chase 50 ml of periplasmic proteins (;1 mg/ml) were
added when indicated, and in the case of a cross-link experiment also 1
mM bis(sulfosuccinimidyl) suberate (BS3) dissolved in labeling medium
(Pierce). After 10 min the cross-linking reaction was quenched on ice
with quench buffer (0.1 M glycine, 10 mM NaHCO3, 250 mM sucrose, pH
8.5). The spheroplasts were subsequently collected by centrifugation for
2 min at 10,000 3 g. Pellet and supernatant were either trichloroacetic
acid-precipitated and immunoprecipitated or used for flotation gradient
centrifugation. In release experiments the samples were not treated
with a cross-linker. The pellet and supernatant fractions were trichlo-
roacetic acid-precipitated and either directly loaded (1/15 of the total
material) on SDS-polyacrylamide gel electrophoresis (PhoE) or immu-
noprecipitated (OmpA). The release values for PhoE presented in the
text are an average of at least three experiments.
Pulse-chase Labeling—Cells were grown exactly as described above
and pulsed for 30 s with [35S]methionine (30 mCi per ml of cells)
followed by a chase with cold methionine (final concentration, 2 mM).
Samples were taken at several time intervals and precipitated with
trichloroacetic acid.
Flotation Gradient Centrifugation—To purify membranes and mem-
brane-associated protein complexes; crude membranes were subjected
to flotation gradient analysis as described previously (28).
Pellet fractions from the spheroplast labeling experiment were re-
suspended in spheroplast-labeling medium and subsequently osmoti-
cally lysed by dilution with 9 volumes of cold water. The lysed cells were
sonicated three times for 10 s. Non-lysed cells were removed by low
speed centrifugation (6000 3 g for 2 min). Subsequently, membranes
were pelleted by centrifugation in a TLA120.2 rotor for 30 min at
300,000 3 g and loaded onto the bottom of a tube that was overlaid with
sucrose. After centrifugation, the two top fractions, containing the
membranes and membrane-associated proteins, were trichloroacetic
acid-precipitated.
In Vitro Transcription and Translation—Ribosome nascent chain
complexes (RNCs) were prepared as follows. pC4MethPhoE-derivative
plasmids were linearized with HindIII and transcribed using a T7
polymerase MEGAscript kit of Ambion Inc. (Austin, TX). Translations
were carried out as described previously (1) with the following modifi-
cations. A lysate was used from a trigger factor-depleted strain, and 100
mM aurin tricarboxylic acid was added 2.5 min after the start of the
translation to inhibit initiation. RNCs were purified by centrifugation
over a sucrose cushion (29). Per standard translation reaction of 12.5 ml
the RNCs were resuspended in 2 ml of RN buffer (100 mM KOAc, 5 mM
Mg(OAc)2, 50 mM Hepes-KOH, pH 7.9), mixed with 10.5 ml of periplas-
mic extract (;1 mg/ml), and treated with 1 mM BS3. In vitro translation
of prePhoE was carried out as described previously (16). Either plasmid
pJP29 (30) (Fig. 7) or pVG01 (24) (Fig. 3) was used. For targeting to the
IM, vesicles were added at the start of the translation reaction, and
cross-linking was carried out with 1 mM DSS as described (1). Trans-
lation reactions were transferred to ice and incubated for 5 min with
chloramphenicol (30 mg/ml) to stop further translations. Subsequently,
mixtures were incubated with proteinase K (0.2 mg/ml) in the absence
or presence of Triton X-100 (1% w/v). The protease reaction was stopped
after 30-min incubation on ice by the addition of 1 mM phenylmethyl-
sulfonyl fluoride.
Immunoprecipitations and Protein Analysis—Trichloroacetic acid
pellets were either directly solubilized with SDS-sample buffer for
SDS-polyacrylamide gel electrophoresis-precipitated proteins or solubi-
lized in SDS-buffer and used in immunoprecipitation reactions under
denaturing conditions. Immunoprecipitations were carried out as de-
scribed previously (31). All samples were analyzed on 10 or 15% SDS-
polyacrylamide gels. Co-immunoprecipitations of in vitro synthesized
PhoE proteins with antibodies directed against Skp were performed as
described previously (16). Radiolabeled proteins were visualized by
phosphorimaging using a Molecular Dynamics PhosphorImager 473
and analyzed using the ImageQuaNT software from Molecular
Dynamics.
RESULTS
Skp Interacts with PhoE at the Periplasmic Side of the Cyto-
plasmic Membrane—PhoE is translocated over the IM in a
non-native state. Upon entering the periplasm, the protein has
to be released from this membrane to assemble into the outer
membrane in its native trimeric structure. We wanted to de-
termine which chaperones and folding catalysts assist in these
processes and to study the timing of the interaction with these
accessory proteins. To that end, we used an unbiased approach
to analyze the molecular environment of the newly translo-
cated PhoE protein or PhoE translocation intermediates at the
periplasmic side of the IM. MC4100 cells containing an induc-
ible phoE gene were converted into spheroplasts, induced for
the expression of PhoE, pulse-labeled with [35S]methionine,
and chased with cold methionine. Subsequently, cells were
treated with the membrane-impermeable cross-linker BS3 ei-
ther in the presence or absence of added periplasmic extract.
After immunoprecipitating the PhoE proteins in the pellet or
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supernatant fractions with anti-sera against PhoE, proteins
that interact with this OMP were identified. As shown in Fig.
1, lanes 13 and 14, a cross-linking product with a molecular
mass of ;52 kDa was found in the supernatant fraction. The
52-kDa product corresponds in size to the combination of one
molecule of PhoE (36 kDa) and one Skp (16 kDa). The band was
absent when periplasmic proteins were not added (lane 11) or
when a periplasmic extract of a skp mutant was used (lane 12).
These data indicated that Skp closely interacts with PhoE
during or after the process of secretion into the spheroplast
medium, as was shown previously (16).
In the spheroplast pellet fraction cross-linking products of
;71, 57, and 52 kDa were detected (lanes 5–8), suggesting that
these products are still associated to the IM. The intensity of
the 71- and 57-kDa bands was independent of the addition of
periplasmic proteins. This indicates that the cross-linking ad-
ducts were not periplasmic, but membrane-associated proteins.
The cross-linking adducts were not further identified, but the
size of the 71-kDa product suggests that this represents a PhoE
dimer. The band of 52 kDa could be immunoprecipitated with a
specific antiserum raised against Skp (lane 9). A faint reaction
was also obtained without the addition of a periplasmic extract
containing Skp (lanes 5 and 6), indicating that the residual
amount of Skp associated with the spheroplasts interacted
with PhoE. These results showed that Skp interacts with PhoE
at the level of the IM. It is, however, also conceivable that the
Skp-PhoE cross-linking product in the pellet fraction repre-
sented an interaction of Skp with PhoE aggregates. To distin-
guish between these possibilities, spheroplasts were lysed and
IMs were purified by flotation gradient centrifugation (Fig. 2).
The vast majority of PhoE protein was associated with the
membranes present in fraction 2 (see lanes 3, 4, and 6). In this
fraction the IM protein YidC (32) was detected as a control
protein (results not shown). Furthermore, the typical three
cross-linking products of 72, 57, and 52 kDa were also detected
in this membrane fraction. The 52-kDa band could be immu-
noprecipitated with either aPhoE (lane 6) or aSkp (lane 8). The
three cross-linking bands could also be obtained when the
cross-linking was carried out after the flotation (lane 4). These
results showed that the SkpzPhoE interaction occurs in close
proximity of the membrane, resulting in a membrane-associ-
ated PhoEzSkp complex.
The interaction of Skp with PhoE at the membrane was also
investigated in vitro. The precursor of PhoE was synthesized in
an E. coli-derived translation system in the presence of in-
verted IM vesicles. The precursors could be imported into these
vesicles with an efficiency of ;25% as was monitored by their
resistance against externally added proteinase K (Fig. 3, lanes
1, 4, and 7). This efficiency of targeting and insertion was also
found in other studies with in vitro synthesized prePhoE (33).
Cross-linking with the membrane-permeable cross-linker DSS
gave rise to a cross-linking product of 52 kDa that could be
immunoprecipitated with anti-serum directed against PhoE
(lanes 2, 5) and Skp (lanes 3 and 6). This cross-linking product
must have been formed, at least for a large part, inside the
vesicles (periplasmic side), because it was resistant to exter-
nally added proteinase K (lanes 5 and 6). Importantly, this
proteinase K-resistant cross-linking product could not be ob-
tained when vesicles were used isolated from a skp mutant
(lanes 13 and 14). The 52-kDa cross-linking product that could
be immunoprecipitated with anti-Skp (lane 11) was degraded
by the protease (lane 14), indicating that the cross-linking
adduct origins from the lysate, which was isolated from the
wild type.
Skp Interacts with a Translocation Intermediate of
PhoE—We subsequently wanted to determine whether Skp
interacts with PhoE during translocation across the IM. Previ-
ously, it was demonstrated that a PhoE-LacZ hybrid protein
spans the IM, with the PhoE moiety in the periplasm and the
b-galactosidase moiety in the cytoplasm. In addition, such LacZ
FIG. 1. PhoE interacts with Skp in
close proximity of the cytoplasmic
membrane. E. coli cells of wild type
MC4100 containing plasmid pNN100
were converted to spheroplasts, induced
with IPTG, and pulse-labeled. During the
chase either buffer (A) or a periplasmic
extract was added from an skp mutant
(B), wild type (C), or an Skp-overproduc-
ing strain (D). In addition, during the
chase the cross-linker BS3 was added
(lanes 5–9, 11–14). The spheroplasts were
collected by centrifugation, and the pellet
and membrane fractions were used in im-
munoprecipitation experiments with ei-
ther aPhoE or aSkp. The cross-link prod-
uct of PhoE with Skp is indicated with an
arrow.
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fusion proteins were shown to block translocation of other
proteins across the IM, due to jamming of the Sec pathway (34).
In other studies dihydrofolate reductase (DHFR) was used to
create OmpA-DHFR translocation intermediates that have
similar effects as LacZ fusions (35) (36). We made use of this
strategy to study the environment of PhoE translocation inter-
mediates. We constructed a hybrid protein containing the N-
terminal 300 amino acid residues of PhoE fused to mouse
DHFR under control of the inducible arabinose promoter. Upon
induction with arabinose, cells harboring the phoE300-dhfr
gene fusion synthesized the hybrid protein and stopped grow-
ing (results not shown). In a pulse-chase experiment it could be
demonstrated that under non-inducing conditions relatively
low amounts of the hybrid protein were synthesized (Fig. 4a).
In these cells, the OmpA protein was rapidly processed to the
mature form (Fig. 4c). Upon induction with arabinose the
PhoE-DHFR hybrid protein was synthesized to increased
amounts and both the hybrid precursor as well as the mature
form were present even after 30 min (Fig. 4b). In addition, the
synthesis of OmpA was reduced and proOmpA accumulated,
indicating that it could not be translocated across the IM (Fig.
4d). These results indicated that the synthesis of the PhoE-
DHFR hybrid protein causes jamming of the Sec translocase.
Proteinase K treatment of spheroplasts that were induced for
synthesis of the hybrid protein and subsequently pulse labeled,
showed that the PhoE moiety of the mature hybrid protein was
degraded by the protease, whereas the DHFR moiety was not
(results not shown). These data demonstrate that the PhoE-
DHFR hybrid protein is in a transmembrane orientation, be-
cause it is accessible for protease added from the outside and it
blocks the translocation apparatus. The vast majority of the
translocons must be occupied with this fusion protein, because
an efficient block in protein export is observed.
To analyze the environment of these translocation interme-
diates, spheroplasts were induced with arabinose, pulse-la-
beled in the presence of additional periplasmic proteins, and
subsequently treated with the soluble cross-linker BS3. In the
pellet fractions several cross-linked bands could be identified
after immunoprecipitation with antisera raised against DHFR
(Fig. 5, lane 3). The strong cross-linking product of ;97 kDa
possibly represented a dimer of the hybrid protein. The very
weak band of ;65 kDa could also be immunoprecipitated with
antiserum raised against Skp (lane 2). In addition, by using
sequential immunoprecipitation we found that this cross-link-
ing product could be immunoprecipitated first by anti-Skp and
subsequently by anti-PhoE (lane 1). The 65-kDa cross-linking
product was membrane-associated, because it was found in the
same two fractions of a flotation gradient as the inner mem-
brane protein YidC (32) (results not shown). These results
demonstrated that the PhoE-DHFR hybrid protein interacted
with Skp and that the interaction of Skp with PhoE occurred
during translocation, i.e. when PhoE is in a transmembrane
orientation. The amount of PhoE-DHFRzSkp complex found in
this experimental setup is much less compared with the
amount of PhoEzSkp found in the experiments described above
and shown in Fig. 1. It is possible that cross-linking targets are
not properly exposed in the hybrid protein, but it is also con-
ceivable that a C-terminal PhoE-truncate binds less efficiently
to Skp compared with the full-length protein.
The Skp Binding Site(s) in PhoE—The results obtained so far
indicate an early interaction between Skp and the first 300
amino acids of PhoE protein. To determine which regions of the
PhoE protein are important for Skp binding, we investigated
whether Skp is able to bind to shorter, nascent chains of PhoE.
PhoE ribosome nascent chain complexes (RNCs) were synthe-
sized in vitro, isolated by centrifugation over a sucrose cushion,
incubated with a periplasmic extract, and subsequently treated
with BS3. In the past we found that nascent chains as long as
50 amino acids could interact with trigger factor (2). Because
trigger factor will block binding sites on the nascent chain in
these experiments, it is required to use a trigger factor-de-
pleted lysate. In addition we used constructs that lack a signal
sequence to mimic the situation at the periplasmic side of the
membrane as good as possible. As shown in Fig. 6a, an RNC
containing 137 amino acids of PhoE gave rise to cross-linking
products of ;32 and ;48 kDa (lane 6). Both cross-linking
products could be immunoprecipitated with aSkp (lane 7) and
represent most probably complexes between the 137-mer of
PhoE and monomeric and oligomeric forms of Skp. The cross-
linking products were not detected when the isolated RNC
complexes were incubated with control buffer (lane 2–4). Sim-
ilar results were obtained with a shorter version of the PhoE
protein. RNCs of a 100-mer of PhoE resulted in cross-linking
products of 29 and 45 kDa that could be immunoprecipitated
with aSkp (Fig. 6b, lanes 5, 6). These products were found when
a wild type periplasm was used but were absent when an
extract was used of a skp mutant strain (lanes 2, 3). The
100-mer of PhoE exposed ;65 amino acid residues out of the
FIG. 2. The PhoEzSkp complex is membrane-associated. E. coli
cells of wild type MC4100 containing plasmid pNN100 were converted
to spheroplasts, induced with IPTG, and pulse-labeled. During the
chase periplasmic extract was added from an Skp-overproducing strain
together with the cross-linker BS3 (lanes 5–8). Membranes were iso-
lated and loaded on a flotation gradient. The gradient was fractionated
into four fractions, and the upper two fractions are shown. The fractions
were used in immunoprecipitation experiments with either aPhoE
(lanes 5, 6) or aSkp (lanes 7, 8). Lanes 1–4 contain the proteins that are
present in membrane fractions that were cross-linked after the flota-
tion. An asterisk indicate the cross-link product of PhoE with Skp.
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ribosome, indicating that a binding site for Skp is present at
the extreme N terminus of PhoE.
Interaction of Skp with Mutant PhoE Proteins Synthesized in
Vitro—De Cock et al. (16) demonstrated that Skp interacts with
PhoE proteins that were synthesized in vitro, because these
PhoE proteins were specifically precipitated with antibodies
directed against Skp. The absence or presence of the signal
sequence did not interfere with complex formation. We used
this approach to study the Skp-binding site of PhoE in more
detail by using a set of PhoE mutants with internal deletions in
the mature part of the protein. Wild type and mutant PhoE
proteins were synthesized in an E. coli derived in vitro system
(Fig. 7, TL). After synthesis, purified Skp was added followed
by the addition of puromycin to release all nascent chains.
PhoE proteins associated to Skp were immunoprecipitated
with antibodies directed against Skp. In all cases PhoEzSkp
complexes could be precipitated (Fig. 7, aSkp). However, the
relative amount of PhoE that could be co-precipitated varied
between the different mutants (Table I). Deletion of amino
acids 3–11 in the mature portion of PhoE protein reduced Skp
binding efficiency only moderately by ;35% as compared with
full-length PhoE protein. However, larger deletions in the N-
terminal part of PhoE protein reduced the binding efficiencies
much further, i.e. .90%. A deletion of amino acids 48–146
reduced the efficiency of binding another 20-fold to .99%. This
can be explained by assuming that two independent Skp-bind-
ing sites exist in the N-terminal part of PhoE protein, i.e.
between 3–91 and 110–174 PhoE. Deletion of amino acids
48–146 would delete a major part of both sites resulting in an
almost complete reduction of binding to Skp.
A mutant PhoE protein containing the N-terminal 204 amino
acids, but lacking the C-terminal part (Fig. 7, lane 9) leads to a
reduction of the binding efficiency with ;65%, suggesting that
indeed the N-terminal part of PhoE protein contains the most
important Skp-binding sites. Interestingly, however, a smaller
deletion in the C-terminal part of PhoE, amino acids 249–298
(Fig. 7, lane 7), reduced the efficiency much further (.90%). In
conclusion, the N-terminal region seems to be important for
Skp binding whereas different parts of the C terminus of PhoE
seem to influence the binding to these N-terminal sites. How-
ever, it cannot be excluded that differences in folding charac-
teristics of the various deletion mutants affect Skp binding due
to alterations in exposure of the Skp-binding sites.
Skp Is Not Responsible for the Release of PhoE from the Inner
FIG. 3. In vitro synthesized PhoE
binds to Skp at the periplasmic side
of the inner membrane. PrePhoE was
synthesized in vitro using an S135 extract
in the presence of inner membrane vesic-
les isolated from wild type (lanes 1-8) or
from an skp mutant (lanes 9–16). After
translocation, the samples were treated
with the membrane permeable cross-
linker DSS and either directly immu-
noprecipitated or after treatment with
proteinase K. An asterisk indicates the
cross-link product of PhoE with Skp.
Molecular masses are indicated in kDa.
FIG. 4. 300PhoE-DHFR forms a
transmembrane translocation inter-
mediate. The translocation of 300PhoE-
DHFR and OmpA was studied in a pulse-
chase experiment. MC4100 containing
para300PhoE-DHFR was incubated with
(b, d) or without (a, c) arabinose. The cells
were immunoprecipitated with either
aPhoE (a, b) or aOmpA (c, d).
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Membrane—Recently, it was proposed that Skp is required for
the release of OmpA protein from spheroplasts. Furthermore,
Skp was proposed to be involved in the acquirement of a soluble
periplasmic form of newly translocated OMPs (15). From the
data presented in Fig. 1 (lanes 1 and 15) we observed that PhoE
remained associated to the membrane to a large extent. Addi-
tion of a periplasmic extract isolated from a Skp-overproducing
strain (Fig. 1, lanes 4 and 18) did not significantly influence the
amount of released PhoE. To investigate the release of PhoE
from the spheroplasts we carried out release experiments and
found that 55% of PhoE remained associated to the membrane
in a wild type strain. It has been reported that the amount of
Skp in spheroplasts is lower in the presence of bivalent cations
(14). When we leave out magnesium ions from our spheroplast
preparations, the amount of PhoE that remained associated to
the membranes was slightly increased (63%). In these sphero-
plast preparations the release of OmpA into the supernatant
was 90%. On the contrary, in the strain lacking Skp protein,
PhoE and OmpA were both for a large part detected in the
pellet fraction (65 and 61%, respectively). The data indicate
that Skp is required for the release and formation of a soluble
form of OmpA protein, whereas the release of PhoE seems to be
independent of Skp.
DISCUSSION
Proteins destined for the extracytoplasmic environment pass
the IM in a non-native conformation. Upon entering the
periplasm, these proteins have to be protected immediately
against degradation, aggregation, and misfolding. To that end,
periplasmic chaperones are supposed to be involved in direct-
ing these proteins into a productive folding and/or assembly
pathway. Little is known which periplasmic chaperones and
folding catalysts are involved in the late stages of IM translo-
cation and the early stages of folding. We used an unbiased
approach to study the early interactions in the periplasm of
accessory proteins with the OMP PhoE, and we found an early
interaction with the periplasmic chaperone Skp. It has been
suggested that Skp plays an important role in these early
events as a specific chaperone for OMPs (15, 16), but the timing
and the location of this interaction was not clear. The data
presented in this paper showed that the initial interaction of
PhoE with Skp occurs at the periplasmic side of the IM. A
hybrid protein consisting of 300 N-terminal amino acids of
PhoE protein fused to mouse DHFR formed a transmembrane
translocation intermediate. This hybrid protein interacted with
Skp as monitored by protein cross-linking, indicating that
PhoE interacts with the chaperone already during transloca-
tion. In addition, the data implicate the presence of one or more
Skp-binding sites in the N-terminal region of PhoE. Indeed, we
found that Skp was able to closely interact with an N-terminal
PhoE fragment of 65 amino acid residues in in vitro cross-
linking experiments. Furthermore, deletions in the N-terminal
as well as the C-terminal part of the PhoE protein resulted in
reduction of precipitation of PhoE with aSkp. The data can be
explained by assuming the presence of two Skp-binding regions
in the N terminus of PhoE. Absence of certain parts of the C
terminus in PhoE mutant proteins might influence the confor-
mation of this protein, and, as a consequence, the exposure of
binding sites is different. The immunoprecipitation experi-
ments were performed in the absence of membranes, which
might influence the manner and extend to which Skp interacts
with PhoE protein. However, it should be emphasized that
detergents are present during immunoprecipitations, which
can be regarded as a membrane-mimicking environment.
Taken together, the results demonstrated that Skp interacts
with PhoE protein once the extreme N-terminal part, contain-
ing these binding sites, appears in the periplasm. We therefore
suggested that early translocation intermediates of OMPs are
already recognized by this molecular chaperone. It is unlikely
that the specific interaction of Skp with OMPs is due to recog-
FIG. 5. The 300PhoE-DHFR translocation intermediate inter-
acts with Skp. MC4100 containing pAra300PhoE-DHFR was con-
verted to spheroplasts, induced with arabinose, and pulse-labeled. Dur-
ing the chase, periplasm from an Skp-overproducing strain and the
cross-linker BS3 was added (lanes 1–3). Pellet fractions were used in
immunoprecipitation experiments with aDHFR (lane 3), aSkp (lane 2),
or aSkp followed by aPhoE (lane 1). The cross-link product of 300PhoE-
DHFR with Skp is indicated with an arrow.
FIG. 6. Skp interacts with ribosome nascent chain complexes
of PhoE. a, ribosome nascent chain complexes of 137 amino acids of
PhoE were synthesized, purified over a sucrose cushion, incubated with
buffer (A) (lanes 1–4) or a periplasmic extract of an Skp-overproducing
strain (D) (lanes 5–8), and subsequently cross-linked with BS3. b, a
100-amino acid nascent chain was used and either incubated with a
periplasmic extract of an skp mutant (B) (lanes 1–3) or of a wild type
strain (C) (lanes 4–6). Cross-linked products were identified by immu-
noprecipitation with either aPhoE or aSkp. The cross-link product of
PhoE with Skp is indicated with an arrow.
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nition of a linear amino acid sequence, because the extreme N
terminus of PhoE protein does not reveal a conserved sequence.
It is therefore more likely that the basis for the selective inter-
action of Skp with OMPs is at the level of recognizing certain
structural elements, possibly b-strands or b-sheets.
Previously, it was demonstrated that Skp exists in two dif-
ferent states characterized by their different sensitivities to
proteases in vivo (16). In addition, Skp was localized as a
soluble periplasmic as well as a membrane-associated protein.
Both forms have apparently the ability to interact with OMPs.
In co-immunoprecipitation and cross-linking experiments to
ribosome-nascent chains, the soluble, protease-sensitive form
was able to form a soluble complex with OMPs. Here, we
demonstrated that full-length PhoE protein, imported into IM
vesicles, interacts with Skp that is co-purified with IM vesicles,
most likely due to association to the membrane. Similar results
have been reported previously for OmpA (15). Interestingly, we
were not able to detect an interaction of membrane-associated
Skp with the PhoE-DHFR hybrid. We had to add additional
periplasmic extract, containing soluble Skp, to obtain cross-
linking. In contrast, cross-linking of Skp to full-length PhoE
protein is possible without the addition of additional periplas-
mic proteins but the efficiency of cross-linking does increase
when periplasm is added. These results do not necessarily
mean that the membrane-associated form of Skp is not able to
interact with the N-terminal portion of the PhoE protein in the
fusion protein per se. It might be that this part has no cross-
linking targets in close proximity of Skp, but it is also possible
that it is has a reduced affinity for binding to membrane-
associated Skp, thereby decreasing the possibility for detection.
In addition, it is possible that the protease-sensitive Skp that
was added with the periplasmic extract is converted to the
resistant form in the spheroplast preparations. This would
raise the Skp concentration to higher levels at the membrane
and allow detection of interaction with the fusion protein by
cross-linking. We propose that the initial interaction of PhoE
translocation intermediates occurs with the membrane-associ-
ated form of Skp.
Scha¨fer et al. (15) suggested that Skp is involved in gener-
ating and maintaining the solubility of early folding interme-
diates of OMPs in the periplasm. In contrast to OmpA, how-
ever, release of the PhoE protein is not dependent on Skp. PhoE
remains associated to the membrane to a large extent even in
wild type spheroplasts. The release of PhoE from the sphero-
plasts was not significantly influenced by bivalent cations or
the addition of addition of periplasmic proteins. Possibly, de
novo synthesis of another or an additional component is neces-
sary to get release of PhoE or the PhoEzSkp complex from the
cytoplasmic membrane. It is not clear why the porin protein
PhoE behaves differently as compared with OmpA in this re-
spect. One possibility is that the assembly of the trimeric por-
ins requires a different assembly route as compared with the
monomeric protein OmpA. In this context it is interesting to
mention that assembly of porins but not OmpA requires de
novo synthesis of lipidic components (either lipopolysaccharide
and/or phospholipids) (37–40). Possibly, the observed differ-
ences in the release of OmpA versus that of the PhoE protein
from spheroplasts is a reflection of this difference in the assem-
bly route.
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